当前位置: X-MOL 学术J. Neurochem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Retraction: Clinical trials in Alzheimer’s disease’: immunotherapy approaches
Journal of Neurochemistry ( IF 4.2 ) Pub Date : 2021-07-06 , DOI: 10.1111/jnc.15435


The article by Julien Delrieu, Pierre Jean Ousset, Céline Caillaud and Bruno Vellas, entitled “‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches”, published in the Journal of Neurochemistry 2012, volume 120, Supplement 1, pages 186-193, published online on August 30, 2011 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/full/10.1111/j.1471-4159.2011.07458.x) has been retracted by agreement between the authors, the journal Editor-in-Chief, Andrew Lawrence, and John Wiley & Sons Limited. The retraction has been agreed due to sections of text being verbatim or almost verbatim from prior publications without direct attribution to the source(s) including from the following sources:



中文翻译:

撤回:阿尔茨海默病的临床试验”:免疫治疗方法

Julien Delrieu、Pierre Jean Ousset、Céline Caillaud 和 Bruno Vellas 撰写的文章,题为“'阿尔茨海默病的临床试验':免疫治疗方法”,发表于Journal of Neurochemistry 2012,第 120 卷,增刊 1,第 186-193 页,已发表在线于 2011 年 8 月 30 日在 Wiley 在线图书馆 (https://onlinelibrary.wiley.com/doi/full/10.1111/j.1471-4159.2011.07458.x) 已被作者同意撤回,期刊编辑 -首席执行官 Andrew Lawrence 和 John Wiley & Sons Limited。由于部分文本逐字或几乎逐字地来自先前出版物,而没有直接归属于包括以下来源在内的来源,因此已同意撤回:

更新日期:2021-08-12
down
wechat
bug